comprehensive -WSS

comprehensive

author：explore 2025-09-03 14:35:42 - browse：683

De-Shaine Murray is working at the cutting edge of neurotechnology. As a postdoctoral fellow at Yale, he is developing a device to monitor the brain following traumatic brain injury or stroke.

He is also trying to fight the long legacy of racism in neuroscience. During 2020, when it was difficult to conduct research, he said, “I got the chance and the ability to read more widely and to just look into the legacy of neuroscience.” He found a direct line from racist pseudoscience like phrenology to disparities in neuroscience today, like how the texture of Black people’s hair can sometimes exclude them from clinical trials because electrodes are not designed for them. In 2021, he co-founded Black in Neuro, an organization dedicated to improving Black representation in neuroscience.

On this episode of the “First Opinion Podcast,” I spoke to him about how the past and present racism in neuroscience could be reflected in the future, especially as neurotechnology like brain implants become more common.

“I’m not saying that whatever electrode that you made or created is racist. But when you have someone who … creates a technology but doesn’t think about the wide range of users that are potentially going to use it, then that’s where the problem comes in,” he told me.

We also discussed the way inequities in neuroscience research are visible in stroke wards, how brain implants might jump from helping disabled people to being used for human enhancement, and more.

Our conversation was inspired by his recent First Opinion essay, “Neuroscience has to grapple with a long legacy of racism if it wants to move into the future.” The book I mention at the end is “Lock In” by John Scalzi, a great sci-fi mystery exploring themes of race, socioeconomic status, neurotechnology, and more.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

LETTER TO THE EDITOR

Have an opinion on this essay? Submit a letter to the editor here.

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： How many hemophilia patients actually want gene therapy?

WSS

Option Care buys Amedisys in $3.6 billion home care deal

Option Care buys Amedisys in $3.6 billion home care deal

PhRMA sues HHS over Medicare drug price negotiation

Pushing for an NIH office for post

UCLA team creates talking throat patch for voice disorders

RaDonda Vaught links Vanderbilt hospital issues to patient death

Wikipedia

comprehensive

LETTER TO THE EDITOR

Have an opinion on this essay? Submit a letter to the editor here.

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Medicare coverage of Wegovy, once blocked, now looks possible

Bright Health sells Medicare Advantage business to Molina

Brain 'hot spot' may explain why African Americans feel greater pain

Sports medicine is finally prioritizing gender equality

Change Healthcare outage fallout shows need for new oversight

Anesthesiologist group: stop taking Ozempic before surgery

Male and female sex labels in research insufficient, scientists say

Medical records are filled with copy

Make 'food is medicine' a key part of White House nutrition meeting

Wikipedia

Pushing for an NIH office for post

New case study details death in closely watched Alzhiemer's trial

Listen: Biogen's messy board & Laronde's data problem

Steward Health Care Massachusetts hospitals face fiscal disaster

Change Healthcare outage fallout shows need for new oversight

Amid AI frenzy, a top HHS official's quest to create safeguards

focus

focus

entertainment

hotspot